Anzeige
Mehr »
Donnerstag, 12.03.2026 - Börsentäglich über 12.000 News
Dieser 37-Mio.-€-Goldentwickler sitzt auf einem möglichen $2-Milliarden-Projekt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
12.02.LEON Closes Funding Round for Nanoparticle Manufacturing Scale-Up
12.02.Iterative Health Adds Nadege Gunn as CMO, Hepatology and Obesity
12.02.Trenchant BioSystems, Invetech Sign Nonbinding Pact to Advance Automated CGT Manufacturing Platform
12.02.Alkermes Acquires Avadel Pharmaceuticals
11.02.Syngene, Johns Hopkins Unite to Advance Early-Stage Drug Discovery
11.02.Rentschler Biopharma Names Veit Bergendahl COO
11.02.Thermo Fisher, Datavant to Partner on Linking Real-World Data to Clinical Research
11.02.PL BioScience Wins Regulatory Certification from Japan's PMDA
11.02.FUJIFILM Biotechnologies Expands in the UK
09.02.Waters Completes Combination With BD Biosciences, Diagnostic Solutions Businesses
09.02.Bruker Introduces Label-Free Characterization Platform for Nanoscale Bioparticles
09.02.Bristol Myers Squibb 4Q Results
09.02.Innovent and Lilly's Seventh Collaboration Sets Model to Accelerate Pipeline Development
09.02.PharmaEssentia to Establish a Manufacturing Subsidiary in Puerto Rico
09.02.Fresenius Kabi, Phlow Partner to Onshore the Manufacture of Epinephrine Injection in the U.S.
09.02.Eurofins Viracor BioPharma Services Expands Service Portfolio
06.02.Samsung Biologics Product Carbon Footprint System Validated by Third Party
06.02.Lilly 4Q Results
06.02.Eisai, Henlius Strike Japan Commercialization Deal for PD-1 Antibody Serplulimab
06.02.FDA Grants Priority Review for Pfizer's HYMPAVZI
05.02.Pfizer 4Q Results
05.02.ADARx Pharmaceuticals Appoints Donald Fong as CMO
05.02.Sanofi 4Q Results
05.02.Braveheart Bio Promotes CSO, Names New SVP
05.02.AbbVie Submits Regulatory Applications for Rinvoq in Patients with Vitiligo